Hepatology

RAAS inhibitor use in MASLD is linked to lower hepatocellular carcinoma risk in a large Taiwan cohort. Find out more from the study findings.

Quantitative MRCP may improve risk prediction and clinical trial development in primary sclerosing cholangitis, an international study suggests.

Rural HCC incidence increased between 2001 and 2022 while urban rates declined, highlighting widening disparities in liver cancer care.

Researchers validate the Liver Disease Stigma Scale, showing higher stigma in alcohol-associated liver disease compared with non-ALD cases.

Brain metastases from HCC remain rare, but selected patients receiving local therapy showed markedly longer survival in a retrospective study.

Multi-echo T2* MRI distinguishes neonatal haemochromatosis from other neonatal liver failure causes by detecting thyroid and pancreatic iron deposition.

Tacrolimus was linked to lower mortality and rejection after liver transplantation, but carried a higher risk of diabetes.

Insulin resistance is independently linked to MASLD in type 1 diabetes, highlighting a distinct high-risk metabolic phenotype in affected patients.